Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1834
Source ID: NCT04853030
Associated Drug: Fiasp
Title: Fast Advanced Closed-Loop Therapy
Acronym: FACT
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 1 Diabetes
Interventions: DRUG: Fiasp|DRUG: Novorapid
Outcome Measures: Primary: Time above range 180 mg/dl, The primary outcomes is a difference in CGM-measured metrics between periods (Minimed 670G 4.0 closed loop with Faster Insulin aspart and Minimed 670G 4.0 closed loop with Standard Insulin aspart) in superiority for proportion of time \>180 mg/dL (10.0 mmol/L), 12 weeks for each arm of the crossover | Secondary: Time in range 70-180 mg/dl, CGM derived indices over the study period of each treatment period ((Minimed 670G 4.0 closed loop with Faster Insulin aspart and Minimed 670G 4.0 closed loop with Standard Insulin aspart)) for 24/7 in time in range 70 to 180 mg/dL (3.9 to 10.0 mmol/L, 4 weeks for each arm of the crossover|Time below range <70 mg/dl, CGM derived indices over the study period of each treatment period ((Minimed 670G 4.0 closed loop with Faster Insulin aspart and Minimed 670G 4.0 closed loop with Standard Insulin aspart)) for 24/7 in time below range 70 mg/dl, 4 weeks for each arm of the crossover|Mean glucose, CGM derived indices over the study period of each treatment period ((Minimed 670G 4.0 closed loop with Faster Insulin aspart and Minimed 670G 4.0 closed loop with Standard Insulin aspart)) for 24/7 in mean glucose, 4 weeks for each arm of the crossover
Sponsor/Collaborators: Sponsor: University of Ljubljana, Faculty of Medicine | Collaborators: Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz, Austria|UMC Ljubljana University Children's Hospital Ljubljana
Gender: ALL
Age: CHILD, ADULT
Phases:
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2021-04-06
Completion Date: 2021-09-20
Results First Posted:
Last Update Posted: 2021-10-01
Locations: Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz, Austria|UMC Ljubljana University Children's Hospital Ljubljana, Ljubljana, 1000, Slovenia
URL: https://clinicaltrials.gov/show/NCT04853030